TOP > 外国特許検索 > PEPTIDE HAVING ACCUMULATION SPECIFIC TO PANCREATIC CANCER, AND USE OF SAID PEPTIDE

PEPTIDE HAVING ACCUMULATION SPECIFIC TO PANCREATIC CANCER, AND USE OF SAID PEPTIDE NEW

外国特許コード F170009109
整理番号 (S2016-0035-N0)
掲載日 2017年6月23日
出願国 世界知的所有権機関(WIPO)
国際出願番号 2016JP081287
国際公開番号 WO 2017086090
国際出願日 平成28年10月21日(2016.10.21)
国際公開日 平成29年5月26日(2017.5.26)
優先権データ
  • 特願2015-226228 (2015.11.19) JP
発明の名称 (英語) PEPTIDE HAVING ACCUMULATION SPECIFIC TO PANCREATIC CANCER, AND USE OF SAID PEPTIDE NEW
発明の概要(英語) The present invention provides a novel peptide having specific accumulation that acts directly on pancreatic cancer cells and tissues. The present invention is a peptide of (a) or (b) below. (a) A peptide comprising an amino acid sequence that includes a sequence represented by any of SEQ ID NOS: 1, 2, 3, or 4. (b) A peptide having accumulation specific to pancreatic cancer, the peptide comprising an amino acid sequence that has 60% or greater identity with a sequence represented by any of SEQ ID NOS: 1, 2, 3, or 4.
特許請求の範囲(英語) [claim1]
1. (A) below or (b) peptide.
(A) Arrangement number the peptide which consists of the amino acid arrangement which includes the arrangement to which is displayed with either 1, 2, 3 or 4,
(B) The peptide which arrangement number consists of the amino acid arrangement which includes the arrangement to which arrangement and the identity where is displayed with either 1, 2, 3 or 4 are 60% or more at the same time, possesses unique accumulation characteristic in the cancer
[claim2]
2. In the claim 1 which is the peptide which consists of L-amino the peptide of statement.
[claim3]
3. In claim 1 or 2 the nuclear acid which features that the cord/code it does the peptide of statement.
[claim4]
4. The vector which features that the nuclear acid of statement is included in claim 3.
[claim5]
5. In claim the carrier which features that the peptide of statement is included 1 or 2.
[claim6]
6. Furthermore, in the claim 5 which has the sign substance or the decoration substance the carrier of statement.
[claim7]
7. The aforementioned sign substance, in the claim 6 which is the stable isotope, the radioisotope or the fluorophor the carrier of statement.
[claim8]
8. The aforementioned decoration substance, in the claim 6 which is the sugar chain or polyethylene glycol or 7 the carrier of statement.
[claim9]
9. Either of the claim 5-8 the medicine composition which features the carrier of statement and that it has the bioactive substance in one section.
[claim10]
10. For cancer remedy or in the claim 9 which is for diagnosis the medicine composition of statement.
  • 出願人(英語)
  • ※2012年7月以前掲載分については米国以外のすべての指定国
  • NIIGATA UNIVERSITY
  • 発明者(英語)
  • KONDO EISAKU
  • SAITO KEN
国際特許分類(IPC)
指定国 (WO201786090)
National States: AE AG AL AM AO AT AU AZ BA BB BG BH BN BR BW BY BZ CA CH CL CN CO CR CU CZ DE DJ DK DM DO DZ EC EE EG ES FI GB GD GE GH GM GT HN HR HU ID IL IN IR IS JP KE KG KN KP KR KW KZ LA LC LK LR LS LU LY MA MD ME MG MK MN MW MX MY MZ NA NG NI NO NZ OM PA PE PG PH PL PT QA RO RS RU RW SA SC SD SE SG SK SL SM ST SV SY TH TJ TM TN TR TT TZ UA UG US UZ VC VN ZA ZM ZW
ARIPO: BW GH GM KE LR LS MW MZ NA RW SD SL SZ TZ UG ZM ZW
EAPO: AM AZ BY KG KZ RU TJ TM
EPO: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
OAPI: BF BJ CF CG CI CM GA GN GQ GW KM ML MR NE SN ST TD TG
ライセンスをご希望の方、特許の内容に興味を持たれた方は、下記「問合せ先」までお問い合わせください。

PAGE TOP

close
close
close
close
close
close